전장 유전체 비설파이트 시퀀싱 시장 규모, 점유율, 성장 분석 : 제품 및 서비스별, 용도별, 최종사용자별, 기술별, 지역별 - 산업 예측(2026-2033년)

Global Whole Genome Bisulfite Sequencing Market size was valued at USD 1.58 Billion in 2024 and is poised to grow from USD 1.81 Billion in 2025 to USD 5.48 Billion by 2033, growing at a CAGR of 14.8% during the forecast period (2026-2033).

The Global Whole Genome Bisulfite Sequencing (WGBS) market is characterized by a diverse range of suppliers providing reagents, library preparation kits, sequencing platforms, and bioinformatics services that facilitate DNA methylation mapping across genomes. This capability is crucial for understanding epigenetic alterations linked to various diseases, including cancer and neurodegeneration. Historically, WGBS was limited to academic settings due to high costs and complexity, but advancements in technology have democratized access, enabling pharmaceutical companies and clinical research groups to incorporate WGBS into biomarker discovery. The rising demand for personalized oncology therapies further propels market growth, as methylation profiles aid patient stratification and drug development, fostering investments in cost-effective WGBS solutions and expanding beyond traditional research applications into precision medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Genome Bisulfite Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Genome Bisulfite Sequencing Market Segments Analysis

Global whole genome bisulfite sequencing market is segmented by product & service, application, end user, technology and region. Based on product & service, the market is segmented into Kits & Reagents, Instruments, Sequencing Services and Bioinformatics Software. Based on application, the market is segmented into Cancer Research, Epigenetics Research, Developmental Biology, Precision Medicine and Agricultural & Plant Genomics. Based on end user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories and Contract Research Organizations. Based on technology, the market is segmented into Short-Read Sequencing and Long-Read Sequencing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Genome Bisulfite Sequencing Market

One of the key market drivers for the global whole genome bisulfite sequencing market is the increasing prevalence of cancer and other genetic disorders. As researchers and clinicians seek to understand the epigenetic alterations that drive these conditions, demand for advanced sequencing technologies like whole genome bisulfite sequencing has surged. This technique allows for comprehensive analysis of DNA methylation patterns, enabling better insights into gene regulation and potential therapeutic targets. Furthermore, the growing focus on personalized medicine, where treatments are tailored based on individual genetic profiles, further propels the need for robust sequencing methods that aid in the identification of epigenetic modifications.

Restraints in the Global Whole Genome Bisulfite Sequencing Market

A key market restraint for the Global Whole Genome Bisulfite Sequencing Market is the high costs associated with sequencing technologies and analysis. The complex nature of whole genome bisulfite sequencing requires sophisticated equipment and specialized personnel, leading to substantial investments in laboratory infrastructure and training. Additionally, the extensive data analysis required to interpret the results adds to the overall expenditure. This financial burden can limit access for smaller laboratories and research institutions, thereby hindering broader adoption and market growth. As a result, many potential users may be deterred from incorporating bisulfite sequencing into their research and clinical applications.

Market Trends of the Global Whole Genome Bisulfite Sequencing Market

The Global Whole Genome Bisulfite Sequencing market is witnessing significant growth, fueled by an increased focus on epigenetic therapeutics. Demand for comprehensive methylation profiling has surged, as pharmaceutical companies seek to leverage whole genome bisulfite sequencing for mapping disease-specific epigenetic signatures. This trend has catalyzed collaborations with specialized service providers, enhancing contract research capabilities and promoting investments in automation and sample preparation workflows. Consequently, the commercial ecosystem surrounding sequencing platforms is expanding, aimed at long-term clinical applications and precision health initiatives. As a result, whole genome bisulfite sequencing is becoming indispensable for advancing epigenetic research and therapeutic development.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Whole Genome Bisulfite Sequencing Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Kits & Reagents
• Instruments
• Sequencing Services
• Bioinformatics Software

Global Whole Genome Bisulfite Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cancer Research
• Epigenetics Research
• Developmental Biology
• Precision Medicine
• Agricultural & Plant Genomics

Global Whole Genome Bisulfite Sequencing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Laboratories
• Contract Research Organizations

Global Whole Genome Bisulfite Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Short-Read Sequencing
• Long-Read Sequencing

Global Whole Genome Bisulfite Sequencing Market Size & CAGR (2026-2033)

• North America (Product & Service, Application, End User, Technology)
  • US
  • Canada
• Europe (Product & Service, Application, End User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, End User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, End User, Technology)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, End User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations